Aliskiren and dual therapy in type 2 diabetes mellitus.
Julie R
JR
Ingelfinger
D000577:Amides / Q000494:pharmacology / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005650:Fumarates / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D011507:Proteinuria / Q000188:drug therapy*; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology; D000092502:Renin Inhibitors
D000577:Amides; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D005650:Fumarates; D019808:Losartan; D000092502:Renin Inhibitors; C446481:aliskiren